EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 30 May 2024

#Imagine if all Europeans had access to new medicines on day one after authorisation

Hear more from Stefan Oelrich, Vice-President of EFPIA and Member of the Board of Management of Bayer AG and Head of its Pharmaceuticals Division.

Blog

New data demonstrates the value of regulatory data protection (RDP), and its impact on European...
28 May 2024 - Nathalie Moll

EFPIA believes EU leaders’ focus on competitiveness is positive but more joined-up thinking is urgently needed to achieve... Read more

Access Gap - How to bridge the gap?

Watch the recording of Nathalie Moll's speech at the 3rd INFARMA Conference 'Access Gap - How to Bridge the Gap?' held in Warsaw.

Nathalie presented EFPIA's view on key EU files such as the Pharmaceutical Legislation and HTA, and voiced her readiness to work together with the future Polish Presidency of the Council of the European Union to create the right innovation ecosystem for Europe and Poland.

Events

IMI impact on antimicrobial resistance
31 May 2024 (Online event)

Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects. Read more

Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?...
04 June 2024 (Online session)

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at... Read more

What we are reading

EU Clinical Trials Discussion Platform Sets Off With Collaborative Tone
On 29 May 2024 (Pink Sheet)

An eagerly-anticipated group has been set up in the EU to hold balanced discussions... Read more

Crossing the bridge – from project to non-profit
On 28 May 2024 (Innovative Health Initiative)

Transitioning from an IMI or IHI project to a non-profit association is one way to ensure... Read more

Belgium developing new class of antibiotics, but incentives and market support needed
On 28 May 2024 (Euractiv)

Europe’s pipeline of new antibiotics to tackle the growing antimicrobial resistance... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu